ENANTA PHARMACEUTICALS, INC Warrants and Rights Outstanding
ENANTA PHARMACEUTICALS, INC (ENTA) had Warrants and Rights Outstanding of $807.00 thousand as of 2017-09-30, per its 10-K filed 2018-11-29.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2018-11-29
- 2017-09-30: Warrants and Rights Outstanding $807.00K.
- 2017-06-30: Warrants and Rights Outstanding $1.29M.
- 2017-03-31: Warrants and Rights Outstanding $1.28M.
- 2016-12-31: Warrants and Rights Outstanding $1.26M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2017-09-30 | $807.00K 10-K · filed 2018-11-29 |
| 2017-06-30 | $1.29M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.28M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.26M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $1.25M 10-K · filed 2017-12-11 |
| 2016-06-30 | $1.24M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.22M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.29M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $1.28M 10-K · filed 2016-12-09 |
| 2015-06-30 | $1.46M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.44M 10-Q · filed 2015-05-08 |
| 2014-09-30 | $1.58M 10-K · filed 2015-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |